Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	TF_II-I	GTF2IRD1 GTF2I	5.66e-05	2	141	2	IPR016659
Domain	calpain_III	CAPN12 CAPN11 CAPN8	8.82e-05	12	141	3	SM00720
Domain	C2_III	CAPN12 CAPN11 CAPN8	8.82e-05	12	141	3	IPR033883
Domain	Calpain_III	CAPN12 CAPN11 CAPN8	8.82e-05	12	141	3	IPR022683
Domain	Calpain_III	CAPN12 CAPN11 CAPN8	1.14e-04	13	141	3	PF01067
Domain	Calpain_domain_III	CAPN12 CAPN11 CAPN8	1.14e-04	13	141	3	IPR022682
Domain	Calpain_cysteine_protease	CAPN12 CAPN11 CAPN8	1.44e-04	14	141	3	IPR022684
Domain	Peptidase_C2	CAPN12 CAPN11 CAPN8	1.79e-04	15	141	3	PF00648
Domain	CysPc	CAPN12 CAPN11 CAPN8	1.79e-04	15	141	3	SM00230
Domain	Peptidase_C2_calpain_cat	CAPN12 CAPN11 CAPN8	1.79e-04	15	141	3	IPR001300
Domain	CALPAIN_CAT	CAPN12 CAPN11 CAPN8	1.79e-04	15	141	3	PS50203
Domain	-	GTF2IRD1 GTF2I	3.36e-04	4	141	2	3.90.1460.10
Domain	GTF2I	GTF2IRD1 GTF2I	3.36e-04	4	141	2	PS51139
Domain	GTF2I	GTF2IRD1 GTF2I	3.36e-04	4	141	2	PF02946
Domain	GTF2I	GTF2IRD1 GTF2I	3.36e-04	4	141	2	IPR004212
Domain	Semaphorin	SEMA3F SEMA5A SEMA3G	4.37e-04	20	141	3	IPR027231
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA3F NOB1 INTS1 IPP KDM6B GTF2IRD1 KLF4 ZDHHC8 HIVEP3 KMT2C NCOR2 PSME4 MTOR IL17RE CLN3 HPS6 EIF4G1 NAV1 HERC1 SNAPC4 ESPL1 RAI1 HTT	3.88e-10	1105	149	23	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SEMA5A GTF2IRD1 NCOR2 RBM25 GTF2I CLN3 YLPM1 EIF4G1 PLA2G4A PLCB3 COASY SNAPC4 ESPL1 NMT1 BAG6 XRCC6	2.44e-07	774	149	16	15302935
Pubmed	Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice.	KLF4 MLH1 HTT	2.66e-06	7	149	3	24204315
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	SMCHD1 SMC6 ZFC3H1 GTF2IRD1 GTF2I BABAM1 MLH1 RPA1 SAP130 SLX4 XRCC6	4.47e-06	453	149	11	29656893
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	SMCHD1 KMT2C NCOR2 RBM25 GTF2I YLPM1 RPA1 XRCC6	5.23e-06	220	149	8	35785414
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NEMP1 PHF20 SMCHD1 INTS1 ZFC3H1 GTF2IRD1 KLF4 RALY KMT2C NCOR2 RBM25 GTF2I BABAM1 YLPM1 RPA1 SAP130 XRCC6 RAI1	1.16e-05	1294	149	18	30804502
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	INTS1 RALY RBM25 GTF2I SLFN11 ZNF598 RPA1 XRCC6 MOV10	1.72e-05	340	149	9	24332808
Pubmed	Alternative splicing and promoter use in TFII-I genes.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	19111598
Pubmed	Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	19109438
Pubmed	Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.	MTOR ALK	1.82e-05	2	149	2	25228590
Pubmed	Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells.	MTOR NMT1	1.82e-05	2	149	2	30154572
Pubmed	Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	19897463
Pubmed	Blockage of cytosolic phospholipase A2 alpha sensitizes aggressive breast cancer to doxorubicin through suppressing ERK and mTOR kinases.	MTOR PLA2G4A	1.82e-05	2	149	2	29307829
Pubmed	Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice.	SMCHD1 DNMT3B	1.82e-05	2	149	2	33004076
Pubmed	Regulation of immunoglobulin promoter activity by TFII-I class transcription factors.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	14645227
Pubmed	Duplication of GTF2I results in separation anxiety in mice and humans.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	22578324
Pubmed	Human DNA helicase B (HDHB) binds to replication protein A and facilitates cellular recovery from replication stress.	HELB RPA1	1.82e-05	2	149	2	22194613
Pubmed	Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase.	MTOR EIF4G1	1.82e-05	2	149	2	15452223
Pubmed	TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	14751286
Pubmed	JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency.	KDM6B KLF4	1.82e-05	2	149	2	33033262
Pubmed	Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.	MTOR CLN3	1.82e-05	2	149	2	16714284
Pubmed	SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease.	SORCS2 HTT	1.82e-05	2	149	2	28469074
Pubmed	Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	20642858
Pubmed	Smarcd1 subunit of SWI/SNF chromatin-remodeling complexes collaborates with E2a to promote murine lymphoid specification.	EDIL3 CD79A	1.82e-05	2	149	2	39232562
Pubmed	Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	12865760
Pubmed	eIF4G-driven translation initiation of downstream ORFs in mammalian cells.	MTOR EIF4G1	1.82e-05	2	149	2	32941651
Pubmed	MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells.	MOV10L1 MOV10	1.82e-05	2	149	2	23093941
Pubmed	Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	11827466
Pubmed	Association of GTF2I and GTF2IRD1 polymorphisms with systemic lupus erythematosus in a Chinese Han population.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	26320362
Pubmed	The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.	PSME4 HTT	1.82e-05	2	149	2	33233776
Pubmed	Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays.	GTF2IRD1 GTF2I	1.82e-05	2	149	2	19205026
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	NEMP1 CACNA1F INTS1 PIDD1 LINC02901 ZNF831 KMT2C PRR35 PRICKLE2 PLCB3 RPA1 XRCC6 RAI1	1.84e-05	736	149	13	29676528
Pubmed	SPIDR is required for homologous recombination during mammalian meiosis.	MLH1 SPIDR RPA1	2.14e-05	13	149	3	36938872
Pubmed	The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.	LAMB1 PLCB3 CDC20 NMT1 RPA1 BAG6 MOV10	2.55e-05	199	149	7	36688959
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	POLR1A SMCHD1 INTS1 RBM25 GTF2I GANAB MTOR YLPM1 EIF4G1 XRCC6 MOV10 RAI1	2.66e-05	653	149	12	22586326
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	HELB KMT2C GTF2I MTOR	3.51e-05	43	149	4	33472061
Pubmed	Modifier genes in mice and humans.	HPS6 PLA2G4A HPS5	4.14e-05	16	149	3	11256068
Pubmed	SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.	RPA1 SLX4 XRCC6	4.14e-05	16	149	3	34187905
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	POLR1A INTS1 GTF2I BABAM1 CDC20 RAI1	4.81e-05	150	149	6	30154076
Pubmed	Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.	WFIKKN2 GDF11	5.45e-05	3	149	2	30814254
Pubmed	Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells.	KLF4 MTOR	5.45e-05	3	149	2	35982899
Pubmed	De novo DNA Methyltransferases Dnmt3a and Dnmt3b regulate the onset of Igκ light chain rearrangement during early B-cell development.	CD79A DNMT3B	5.45e-05	3	149	2	26059604
Pubmed	Cutting edge: Expression of the transcription factor E74-like factor 4 is regulated by the mammalian target of rapamycin pathway in CD8+ T cells.	KLF4 MTOR	5.45e-05	3	149	2	20802152
Pubmed	ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells.	SEMA3F ABL2	5.45e-05	3	149	2	18660502
Pubmed	Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.	MLH1 DNMT3B	5.45e-05	3	149	2	28220037
Pubmed	Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.	KLF4 ULBP3	5.45e-05	3	149	2	38780505
Pubmed	[Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].	MTOR ALK	5.45e-05	3	149	2	19176054
Pubmed	Characterization of BLOC-2, a complex containing the Hermansky-Pudlak syndrome proteins HPS3, HPS5 and HPS6.	HPS6 HPS5	5.45e-05	3	149	2	15030569
Pubmed	The Hermansky-Pudlak syndrome 3 (cocoa) protein is a component of the biogenesis of lysosome-related organelles complex-2 (BLOC-2).	HPS6 HPS5	5.45e-05	3	149	2	14718540
Pubmed	Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease.	CLN3 SIGLEC1	5.45e-05	3	149	2	26775238
Pubmed	Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.	MTOR CD79A	5.45e-05	3	149	2	27521345
Pubmed	JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.	KDM6B F8	5.45e-05	3	149	2	28328977
Pubmed	MeCP2 regulates Gdf11, a dosage-sensitive gene critical for neurological function.	EDIL3 GDF11	5.45e-05	3	149	2	36848184
Pubmed	Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1.	GTF2IRD1 GTF2I	5.45e-05	3	149	2	15941713
Pubmed	The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.	GTF2IRD1 GTF2I	5.45e-05	3	149	2	22608712
Pubmed	Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.	KLF4 MTOR	5.45e-05	3	149	2	31432191
Pubmed	Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.	GTF2IRD1 GTF2I	5.45e-05	3	149	2	31418010
Pubmed	Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation.	NCOR2 CD79A	5.45e-05	3	149	2	36316474
Pubmed	The SUMO ubiquitin-protein isopeptide ligase family member Miz1/PIASxbeta /Siz2 is a transcriptional cofactor for TFII-I.	GTF2IRD1 GTF2I	5.45e-05	3	149	2	12193603
Pubmed	DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis.	SMCHD1 DNMT3B	5.45e-05	3	149	2	38809976
Pubmed	Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.	ZFC3H1 NCOR2 RBM25 GTF2I BAG6 XRCC6	7.13e-05	161	149	6	32572027
Pubmed	BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.	LAMB1 MTOR HPS6 NAV1 METTL16 SLX4 MOV10 HTT SMAD9	8.68e-05	419	149	9	33001583
Pubmed	Evolutionarily-conserved MZIP2 is essential for crossover formation in mammalian meiosis.	POLR1A MLH1 RPA1	9.68e-05	21	149	3	30272023
Pubmed	The shieldin complex mediates 53BP1-dependent DNA repair.	QPCTL SYDE1 GTF2I COASY	9.99e-05	56	149	4	30022168
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	QPCTL SMCHD1 NOB1 ZFC3H1 EDIL3 RALY RBM25 PTPN14 GTF2I EIF4G1 NAV1 CDC20 ZNF598 NMT1 XRCC6 MOV10	1.04e-04	1257	149	16	36526897
Pubmed	The early embryonic expression of TFII-I during mouse preimplantation development.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	14678824
Pubmed	Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11.	WFIKKN2 GDF11	1.09e-04	4	149	2	18596030
Pubmed	Evolution of general transcription factors.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	23229069
Pubmed	FMRP and MOV10 regulate Dicer1 expression and dendrite development.	MOV10L1 MOV10	1.09e-04	4	149	2	34847178
Pubmed	Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.	MTOR SMAD9	1.09e-04	4	149	2	22452883
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	22899722
Pubmed	Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.	MTOR HTT	1.09e-04	4	149	2	25351248
Pubmed	Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.	EDIL3 CD79A	1.09e-04	4	149	2	35120522
Pubmed	Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.	RPA1 XRCC6	1.09e-04	4	149	2	10064605
Pubmed	Functions of MutLalpha, replication protein A (RPA), and HMGB1 in 5'-directed mismatch repair.	MLH1 RPA1	1.09e-04	4	149	2	19515846
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	17823943
Pubmed	Altered secretion of kidney lysosomal enzymes in the mouse pigment mutants ruby-eye, ruby-eye-2-J, and maroon.	HPS6 HPS5	1.09e-04	4	149	2	6776948
Pubmed	HPS6 interacts with dynactin p150Glued to mediate retrograde trafficking and maturation of lysosomes.	HPS6 HPS5	1.09e-04	4	149	2	25189619
Pubmed	A dominant-negative mutant of human DNA helicase B blocks the onset of chromosomal DNA replication.	HELB RPA1	1.09e-04	4	149	2	12181327
Pubmed	SLFN11 Blocks Stressed Replication Forks Independently of ATR.	SLFN11 RPA1	1.09e-04	4	149	2	29395061
Pubmed	Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia.	NCOR2 MTOR	1.09e-04	4	149	2	21343542
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	21328569
Pubmed	Ribosomes guide pachytene piRNA formation on long intergenic piRNA precursors.	PNLDC1 MOV10L1	1.09e-04	4	149	2	32015435
Pubmed	Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	12239342
Pubmed	Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.	GTF2IRD1 GTF2I	1.09e-04	4	149	2	32313931
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	POLR1A SMCHD1 SMC6 INTS1 RALY NCOR2 RBM25 GTF2I YLPM1 EIF4G1 METTL16 RPA1 SAP130 XRCC6	1.25e-04	1014	149	14	32416067
Pubmed	Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.	KLF4 RALY NCOR2 GTF2I RPA1	1.31e-04	113	149	5	23403292
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PHF20 SMC6 LAMB1 EDIL3 RALY GTF2I GANAB YLPM1 EIF4G1 CDC20 ESPL1 SLX4 VPS13B XRCC6 MOV10	1.39e-04	1155	149	15	20360068
Pubmed	Human transcription factor protein interaction networks.	NEMP1 SMCHD1 KLF4 KMT2C NCOR2 RBM25 GTF2I GANAB YLPM1 EIF4G1 RASSF8 HERC1 RPA1 SAP130 SLX4 XRCC6 MOV10	1.41e-04	1429	149	17	35140242
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	SMCHD1 IPP RBM25 BABAM1 MTOR SLFN11 CDC20 RPA1 USH2A XRCC6 MOV10	1.57e-04	670	149	11	22990118
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	LAMB1 GTF2I GANAB BABAM1 PSME4 MTOR EIF4G1 PLA2G4A PLCB3 COASY HERC1 NMT1 RPA1 BAG6 XRCC6 HTT VAT1	1.75e-04	1455	149	17	22863883
Pubmed	Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase.	MTOR EIF4G1	1.81e-04	5	149	2	10753870
Pubmed	Facioscapulohumeral Muscular Dystrophy	SMCHD1 DNMT3B	1.81e-04	5	149	2	20301616
Pubmed	Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.	SEMA3F SEMA3G	1.81e-04	5	149	2	18818766
Pubmed	Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodies.	MTOR CD79A	1.81e-04	5	149	2	24336796
Pubmed	Progenitor cell defect correctable by bone marrow transplantation in five independent mouse models of platelet storage pool deficiency.	HPS6 HPS5	1.81e-04	5	149	2	3516713
Pubmed	SHPRH regulates rRNA transcription by recognizing the histone code in an mTOR-dependent manner.	POLR1A MTOR	1.81e-04	5	149	2	28400511
Pubmed	Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function.	HPS6 HPS5	1.81e-04	5	149	2	2369371
Pubmed	Williams Syndrome	GTF2IRD1 GTF2I	1.81e-04	5	149	2	20301427
Pubmed	Apoptotic cell fragments locally activate tingible body macrophages in the germinal center.	CD79A SIGLEC1	1.81e-04	5	149	2	36868219
Interaction	TOP3B interactions	SEMA3F NOB1 INTS1 IPP KDM6B GTF2IRD1 KLF4 ZDHHC8 HIVEP3 KMT2C NCOR2 GTF2I PSME4 MTOR IL17RE CLN3 HPS6 EIF4G1 NAV1 HERC1 SNAPC4 ZNF598 ESPL1 NMT1 RPA1 XRCC6 MOV10 RAI1 HTT	4.73e-07	1470	144	29	int:TOP3B
Interaction	PHF20 interactions	PHF20 KDM6B KMT2C PTPN14 MOV10 HTT	2.09e-06	53	144	6	int:PHF20
Interaction	CAPN11 interactions	CAPN12 CAPN11 CAPN8 XRCC6	4.26e-06	16	144	4	int:CAPN11
Interaction	HDLBP interactions	ABL2 QPCTL KCTD13 SMCHD1 RALY RBM25 GTF2I YLPM1 EIF4G1 MLH1 SLFN11 ZNF598 NMT1 RPA1 ALK SLX4 XRCC6 HTT SMAD9	1.12e-05	855	144	19	int:HDLBP
Interaction	SRGAP2 interactions	KCTD13 KDM6B SYDE1 DENND4C PTPN14 FGD4 YLPM1 PRICKLE2 NAV1	1.24e-05	197	144	9	int:SRGAP2
GeneFamily	C2 domain containing\|Calpains	CAPN12 CAPN11 CAPN8	7.77e-05	15	103	3	975
GeneFamily	Biogenesis of lysosomal organelles complex 2	HPS6 HPS5	9.61e-05	3	103	2	1038
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA3F SEMA5A SEMA3G	1.91e-04	20	103	3	736
GeneFamily	UPF1 like RNA helicases	MOV10L1 MOV10	1.71e-03	11	103	2	1169
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MFAP3L MFAP3 HMCN2 WFIKKN2 SIGLEC1	2.28e-03	161	103	5	593
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEMP1 KATNB1 IPP HELB IL17RE CDC20 RPA1	1.96e-06	172	150	7	ba36581ae339191a12a6d3ead39eaf69d78be10e
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F8 DENND4C GIPR MTOR KCNJ5 YLPM1 HERC1	2.12e-06	174	150	7	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	C15orf62 SMCHD1 CYP2W1 CAPN8 RBM25 HERC1	6.55e-06	135	150	6	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GTF2IRD1 MFAP3L NCOR2 HMCN2 KCNJ5 EIF4G1	1.29e-05	152	150	6	ca23261d8ef263cc697b8d7e7cb2afec8bc564f2
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	SMCHD1 HELB KMT2C RBM25 PSME4 HERC1	1.50e-05	156	150	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GTF2IRD1 MFAP3L NCOR2 HMCN2 KCNJ5 EIF4G1	1.73e-05	160	150	6	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-ectodermal/neuroectodermal-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	NEURL2 MAL2 IL17RE PRICKLE2 SLFN11 CDC20	2.68e-05	173	150	6	7e4a2f5f92fbed16406bd097c0119278e4053245
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	C15orf62 ABCA13 LMTK3 MAL2 SORCS2 PLA2G4A	2.77e-05	174	150	6	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SEMA3F SEMA5A DNAJC22 NUPR2 CAPN8 SLC5A8	3.45e-05	181	150	6	faff2a34e391d053a17c926540e6cb46d94dd629
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SEMA3F SEMA5A DNAJC22 NUPR2 CAPN8 SLC5A8	3.45e-05	181	150	6	5a9c332c0bf07cc20eaf8cf77b45e73668a6467d
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SEMA3F SEMA5A DNAJC22 NUPR2 CAPN8 SLC5A8	3.45e-05	181	150	6	488a517f6e5543b648a2e72e0e04332fad776de6
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SEMA3F SEMA5A DNAJC22 NUPR2 CAPN8 SLC5A8	3.45e-05	181	150	6	58651853f9c715075889856793df66ebe00c04f1
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SEMA3F SEMA3G F8 PTPN14 HMCN2 SMAD9	3.79e-05	184	150	6	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF5 C5AR2 F8 HIVEP3 PTPN14 NAV1	3.90e-05	185	150	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	SEMA3F C5AR2 PHKA1 PIGT TXNDC16 HTT	4.14e-05	187	150	6	a716b64ca03d9b61da765bf87f065ac9393303f1
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	SAP25 C5AR2 LAMB1 MTOR PLCB3 METTL16	4.40e-05	189	150	6	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SAP25 C5AR2 LAMB1 FGD4 MTOR PLCB3	4.40e-05	189	150	6	a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAP25 C5AR2 LAMB1 FGD4 MTOR PLCB3	4.40e-05	189	150	6	54a45b0cb7dea01caf1cf0a2664c40e5779a0b61
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 ARHGEF5 LAMB1 EDIL3 CYP2W1 SMAD9	4.53e-05	190	150	6	a5db902ad112a0c0a0a7f1a2e38718bb3bd11412
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR2 KLF4 PSME4 SORCS2 CD79A XRCC6	4.66e-05	191	150	6	318323a12029a7992f16382cb0c186f5b2e1ca47
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISLR2 KLF4 PSME4 SORCS2 CD79A XRCC6	4.66e-05	191	150	6	4aa29337f4d2528577bb90dc4abfb6eab93e120f
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMCHD1 ZFC3H1 HELB KMT2C RBM25 HERC1	5.53e-05	197	150	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMCHD1 ZFC3H1 HELB RBM25 HERC1 VPS13B	5.85e-05	199	150	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA3F ABCA13 HLF SEMA5A CYP2W1 SORCS2	5.85e-05	199	150	6	94a7867e800df352731796de8c24cba133c29622
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KLK10 ABCA13 LMTK3 CAPN8 MAL2 SLC5A8	5.85e-05	199	150	6	ec1e110671e7725f752163c7241dbbf638dec2b2
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	NEURL2 MFAP3L MTOR PLA2G4A SIGLEC1 RASSF8	5.85e-05	199	150	6	fd75dccb37d96448edf72b7d042b06833d4ead24
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KCTD13 PSME4 YLPM1 SPIDR SAP130 MOV10	6.02e-05	200	150	6	0d76b006d8e8b32174e65e400acd0674354b962c
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KCTD13 PSME4 YLPM1 SPIDR SAP130 MOV10	6.02e-05	200	150	6	cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	SEMA3F PHF20 C5AR2 LAMB1 ANKMY1 PTPN14 PLCB3 RASSF8 SNAPC4	5.42e-06	195	148	9	6082_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SEMA3F ABL2 QPCTL KATNB1 NKX3-2 KDM6B PTPN14 NMT1 VPS13B	5.65e-06	196	148	9	6065_DN
Drug	Carisoprodol [78-44-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	PHF20 PIDD1 EDIL3 MFAP3L CYP2W1 HIVEP3 GIPR RAI1 PDE11A	6.14e-06	198	148	9	6610_UP
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	POLR1A KCTD13 SMCHD1 HIVEP3 GIPR MFAP3 YLPM1 COASY NMT1 RPA1 HTT	1.32e-06	364	139	11	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	body fat percentage	POLR1A KCTD13 SMCHD1 HIVEP3 GIPR MFAP3 YLPM1 COASY NMT1 RPA1 HTT	2.11e-05	488	139	11	EFO_0007800
Disease	FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B	SMCHD1 DNMT3B	2.20e-05	2	139	2	C1834671
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN12 CACNA1F CAPN11 CAPN8	2.47e-05	36	139	4	DOID:11723 (implicated_via_orthology)
Disease	pulse pressure measurement	QPCTL ETFDH IPP KDM6B ZNF831 DENND4C KCNH4 HIVEP3 MAL2 GIPR RBM25 NAV1 COASY LINC02694 NMT1 TRIM49B BAG6 XRCC6 DNMT3B	3.02e-05	1392	139	19	EFO_0005763
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN12 ATP13A5 CAPN11 CAPN8	5.05e-05	43	139	4	DOID:2476 (implicated_via_orthology)
Disease	attention function measurement	DENND5B ZNF831 MAL2 WFIKKN2 SORCS2 ALK	7.47e-05	148	139	6	EFO_0007636
Disease	hereditary spastic paraplegia 76 (implicated_via_orthology)	CAPN11 CAPN8	2.18e-04	5	139	2	DOID:0110821 (implicated_via_orthology)
Disease	laurylcarnitine measurement	ETFDH PCDH8	4.56e-04	7	139	2	EFO_0021041
Disease	Hermansky-Pudlak syndrome (is_implicated_in)	HPS6 HPS5	4.56e-04	7	139	2	DOID:3753 (is_implicated_in)
Disease	Williams Syndrome	GTF2IRD1 GTF2I	6.06e-04	8	139	2	C0175702
Disease	hypertension	ZNF831 NCOR2 FGD4 SORCS2 PLCB3 BAG6 MOV10	6.53e-04	307	139	7	EFO_0000537
Disease	Autism Spectrum Disorders	GTF2I USH2A RAI1 DNMT3B	7.11e-04	85	139	4	C1510586
Disease	airway imaging measurement	POLR1A HIVEP3 RPA1	7.65e-04	38	139	3	EFO_0007627
Disease	platelet component distribution width	CAPN12 HLF ZNF831 C4orf54 NCOR2 CLN3 MOV10L1 MLH1 SIGLEC1 HERC1 GP1BB	9.24e-04	755	139	11	EFO_0007984
Disease	Hermanski-Pudlak Syndrome	HPS6 HPS5	9.67e-04	10	139	2	C0079504
Disease	Hermansky-Pudlak syndrome	HPS6 HPS5	9.67e-04	10	139	2	cv:C0079504
Disease	susceptibility to influenza measurement	SORCS2 NMT1	9.67e-04	10	139	2	EFO_0803537
Disease	dyslexia	SEMA3F MOV10L1 NMT1 HTT DNMT3B	1.04e-03	162	139	5	EFO_0005424
Disease	breast carcinoma	PHF20 ARHGEF5 ETFDH PIDD1 KLF4 RALY HIVEP3 GIPR GTF2I BABAM1 PLA2G4A KLHL18 XRCC6	1.09e-03	1019	139	13	EFO_0000305
Disease	Pancreatic Ductal Adenocarcinoma	ADAM11 SYDE1	1.18e-03	11	139	2	C1335302
Disease	high density lipoprotein particle size measurement	ETFDH NCOR2 PIGT PLCB3 RAI1	1.29e-03	170	139	5	EFO_0008592
Disease	Night blindness, congenital stationary, type 1	CACNA1F GPR179	1.41e-03	12	139	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	CACNA1F GPR179	1.41e-03	12	139	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	CACNA1F GPR179	1.41e-03	12	139	2	C1864877
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	CACNA1F GPR179	1.41e-03	12	139	2	C1850362
Disease	X-Linked Csnb	CACNA1F GPR179	1.41e-03	12	139	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	CACNA1F GPR179	1.41e-03	12	139	2	C1848172
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP3 SMAD9	1.66e-03	13	139	2	DOID:0050787 (implicated_via_orthology)
Disease	Cone-rod synaptic disorder, congenital nonprogressive	CACNA1F GPR179	1.66e-03	13	139	2	C4041558
Disease	Colorectal Carcinoma	ABCA13 ETFDH IPP KCNH4 HIVEP3 KMT2C EIF4G1 MLH1 PZP SMAD9	1.86e-03	702	139	10	C0009402
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	ATP13A5 CLN3	1.93e-03	14	139	2	DOID:14503 (implicated_via_orthology)
Disease	health literacy measurement	FGD4 DBX1 SLC5A8	2.02e-03	53	139	3	EFO_0010104
Disease	Williams-Beuren syndrome (implicated_via_orthology)	GTF2IRD1 GTF2I	2.22e-03	15	139	2	DOID:1928 (implicated_via_orthology)
Disease	nervousness	ETFDH YLPM1	2.53e-03	16	139	2	NCIT_C74532
Disease	cholesteryl esters to total lipids in large HDL percentage	ETFDH NCOR2 PLCB3	2.74e-03	59	139	3	EFO_0022248
Disease	Night blindness, congenital stationary	CACNA1F GPR179	2.86e-03	17	139	2	C0339535
Disease	acylcarnitine measurement	ETFDH MAL2 HERC1 USH2A	3.12e-03	127	139	4	EFO_0005059
Disease	body surface area	POLR1A SMCHD1 GIPR NCOR2 MFAP3 MTOR RPA1 SMIM44 PDE11A	3.50e-03	643	139	9	EFO_0022196
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR PLA2G4A	3.57e-03	19	139	2	DOID:0080322 (biomarker_via_orthology)
Disease	total lipids in very large HDL measurement	ETFDH CYP2W1 PIGT	3.77e-03	66	139	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	ETFDH CYP2W1 PIGT	3.77e-03	66	139	3	EFO_0022298
Disease	ovarian neoplasm	KLK10 BABAM1 MTOR MLH1	3.77e-03	134	139	4	C0919267
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	ETFDH CYP2W1 NCOR2 PIGT PLCB3 RAI1	3.87e-03	315	139	6	EFO_0004612, EFO_0008591
Disease	Malignant neoplasm of ovary	KLK10 BABAM1 MTOR MLH1	4.08e-03	137	139	4	C1140680
Disease	gestational age	HIVEP3 MOV10L1 PRICKLE2 ALK	4.19e-03	138	139	4	EFO_0005112
Disease	cholesterol in very large HDL measurement	ETFDH CYP2W1 PIGT	4.27e-03	69	139	3	EFO_0022229

Protein segments in the cluster

Peptide	Gene	Start	Entry
ILIYETPRGPDPALL	KCTD13	266	Q8WZ19
RYIPSLPDRILDAPE	CDC20	166	Q12834
PYRPAGQLLSPPLLL	ATP13A5	961	Q4VNC0
LALYKRGRRTPPVQP	CCDC61	276	Q9Y6R9
RASLYPPTLLEGPLR	CTAGE1	501	Q96RT6
PKLYPAIPAARRRPI	DNMT3B	561	Q9UBC3
VPYLPRLPILPSKTR	ABL2	566	P42684
ILRYVRRVGDPPQPL	BAG6	936	P46379
GSSRIYRPLPPLPII	ARHGEF5	831	Q12774
QGPLPHLIYRTPLLP	ADAM11	181	O75078
LQRYRLLPPPGVSPA	CYP2W1	451	Q8TAV3
VRPLATEYPPLRLTP	ABCA13	4246	Q86UQ4
AILSRDRLLPRPGPY	GIPR	186	P48546
RARLPPGEYLVVPST	CAPN8	476	A6NHC0
TYLRVRQPPPRPFLD	CD79A	121	P11912
QLRLPPGEYIIIPST	CAPN11	511	Q9UMQ6
IPLRTNLPPPFRNYK	C2orf76	46	Q3KRA6
ETPLGIRPLTKIPPY	ARMCX5	256	Q6P1M9
PGKPYRLILRPQAPD	ISLR2	621	Q6UXK2
IPERTLYRQSLPPLA	RASSF8	96	Q8NHQ8
RPYLGPALLLTPRDR	RAI1	1466	Q7Z5J4
RLFDYRGRLSPVPVP	RALY	126	Q9UKM9
RRFPVAPLIPYPLIT	RBM25	246	P49756
PRNELIPLIYLENPR	PZP	156	P20742
TYLRPLLVVRTPGSP	QPCTL	96	Q9NXS2
GEPPAVPYPRRLVVL	TSPOAP1	786	O95153
EVLDPIRFPLLPPQR	IPP	221	Q9Y573
KREGRLLQYLPSPPL	KCNJ5	371	P48544
PPQRGRLLYAPLLLV	CACNA1F	1841	O60840
LVPPVLNPILYGART	OR52D1	286	Q9H346
LDLRRPPSDLYLPPP	NCOR2	2171	Q9Y618
PIYLPPILAARPHLR	C22orf23	81	Q9BZE7
AELLRPELDPVYIPP	KLF4	201	O43474
ARYIEELARSVPLPP	MFAP3L	231	O75121
VLNPRGLRYSLPTPK	NOB1	316	Q9ULX3
RIPDSYARPLLTPAP	KMT2C	2021	Q8NEZ4
FDPLLALYAPRLPPI	LSM11	31	P83369
LPSFLPQYPIPDRLR	MOV10L1	491	Q9BXT6
LYRLPETPKTAGLRP	NMT1	326	P30419
LYLQRPELRVPVPEV	INTS1	1806	Q8N201
DPRVYRALLTFNPPP	GPR179	141	Q6PRD1
RYGLRVNVPPRITLP	HMCN2	1976	Q8NDA2
VPLLPELYSVPPDRV	PHKA1	366	P46020
GQLRPLLAPRVYTLP	HERC1	4441	Q15751
LPPLPVITLRSEPQY	HPS5	266	Q9UPZ3
GDIPPPLRALPRYRL	IL17RE	601	Q8NFR9
LPREKLNPPTPSIYL	KDM6B	1176	O15054
LPNPSAPLRRIYERP	KATNB1	326	Q9BVA0
LQLTYLLSERPPRPP	LMTK3	406	Q96Q04
PPALRGRLLPYLAED	GP1BB	121	P13224
LYLFPREDPPRLLFP	LINC02901	161	Q4VX62
SRPTPILPLIYIREN	PCSK4	461	Q6UW60
RLQALARPPPPISYE	NUPR2	11	A6NF83
YDRTVTLLSPPRPGR	PCDH8	1026	O95206
LESRVNLPRYPPTAI	PDE11A	176	Q9HCR9
PVPPRLLTEEEYRIQ	NEMP1	336	O14524
VEDLIRISRPPAYLP	DBX1	41	A6NMT0
YRTPGIGPVLPLEER	FGD4	156	Q96M96
LLDLRPSILPPYPSE	KCNH4	971	Q9UQ05
PLERLIPTVPLRLNY	METTL16	71	Q86W50
SLSPGSRYVVLPRPV	LAMB1	656	P07942
PVVNSLDPPLLTRYL	F8	2311	P00451
PPPYGVLRSLLENPL	HLF	16	Q16534
SRPPTLLVEPYLRIE	NEURL2	136	Q9BR09
YPTVPRGEELLRLAP	ALAS2	506	P22557
YIEELARSVPLPPLI	MFAP3	231	P55082
LLQPRVTPEGEYIPL	KCNJ14	236	Q9UNX9
QRPTPAPRLYYPLLL	PRR35	256	P0CG20
LGEPIPQPARLRYVT	PRICKLE2	791	Q7Z3G6
DPRLNEVLYPPLRPS	PLCB3	256	Q01970
EVLYPPLRPSQARLL	PLCB3	261	Q01970
RQYLPGEVLRPPSLL	NKX3-2	291	P78367
RPITTGNSPPRYRLL	RPA1	31	P27694
VIDPPIYARHIRILP	EDIL3	446	O43854
TEKYRIPVPILPGLP	ETFDH	151	Q16134
LYPRLLRRVVPPGQD	CAPN12	116	Q6ZSI9
LVSTPQRPPLYLERI	ESPL1	86	Q14674
RLPLVNSYTRVPPLV	HTT	2401	P42858
RGPYLPELLSNIRLP	KLHL18	216	O94889
PPPYVVRTILVYSRP	BABAM1	206	Q9NWV8
IDPLRVAPLPLYAAI	C5AR2	31	Q9P296
YLAARTLEIPLPNRP	CCNL2	246	Q96S94
PVPRPATVYLQILRL	GDF11	186	O95390
NILYEVPLPPPGRSL	DENND5B	231	Q6ZUT9
PPVSVPYLSPLVLRK	DENND4C	1681	Q5VZ89
YELRPPPAPLLLPRV	ANKMY1	391	Q9P2S6
YRLSPEPTPLAEPIL	EIF4G1	311	Q04637
PRVTLPAGPDILRTY	MAL2	21	Q969L2
PLPYERLLREPGLLA	GTF2IRD1	151	Q9UHL9
IPFRRPSTYGIPRLE	GTF2I	406	P78347
LLLRTYLPDEVGPPT	HPS6	706	Q86YV9
NLARERPRSLYIPPV	C4orf54	1361	D6RIA3
PLLPTRLPDDYIILP	RTL8C	126	O15255
TSPIFYGRPIAILPI	DNAJC22	141	Q8N4W6
RQALPLLPPLLYGVI	SLC22A11	486	Q9NSA0
PYLRQLQGPLLPPRD	HELB	6	Q8NG08
ATPITIRYRLLLPEP	PIDD1	351	Q9HB75
IRYRLLLPEPGLVPL	PIDD1	356	Q9HB75
LPYPLILRPQRGVDL	PLA2G4A	556	P47712
PLALPLPRSVEESYI	PHF20	821	Q9BVI0
YLPRVLDIIRAALPP	MTOR	451	P42345
PSRIPRGPYAEVKPL	NAV1	171	Q8NEY1
DPLLPRGQRVPLYLS	SAP25	86	Q8TEE9
PRQSPDVAPYLRPKR	SYDE1	606	Q6ZW31
PYIRERPPLVPLQKR	USH2A	5071	O75445
FLVVPPSRYRPVSRL	POLR1A	301	O95602
RLPLLSRTLEPYILP	SMCHD1	1596	A6NHR9
YPLQRRPLVVRTGAP	SEMA3F	446	Q13275
LGTYYPPPRLRQLLP	MOV10	291	Q9HCE1
PRYRVPDVLVADPPI	GANAB	111	Q14697
SGPDYPSIRPPILIL	PNLDC1	411	Q8NA58
RSSLPRQQPYILPPV	PTPN14	326	Q15678
LPTLADLYVLLPPPR	SORCS2	1011	Q96PQ0
DLYVLLPPPRPTRKR	SORCS2	1016	Q96PQ0
PPLSDQYPREELTRI	SLFN11	716	Q7Z7L1
QIYPPLPERTLPLHL	SLC5A8	461	Q8N695
YVPPLEGLPIFILRL	MLH1	646	P40692
YTARLVPPLVPQRPA	SLX4	546	Q8IY92
YRRVETPVLPPVLVP	SMAD9	131	O15198
DPAIYRSLGILPPLR	SEMA5A	191	Q13591
PPLQPREPLSYSRLQ	ALK	36	Q9UM73
PLGLHLLPYSPRVLV	CLN3	116	Q13286
LGNLLRPPYERPELP	COASY	341	Q13057
YLTVPRRSPLPVFLR	LINC02694	126	Q8NAA6
LLAPPKPPRLYRESS	C15orf62	76	A8K5M9
SPAILPRLAILPYLL	ULBP3	6	Q9BZM4
TPRRNIPPYFVALVP	XRCC6	401	P12956
GILRAYFDPLPPLPL	TXNDC16	676	Q9P2K2
YPILSLPVPPRRVGI	TRIM68	411	Q6AZZ1
VRLYTEPLLVNLPTP	PIGT	506	Q969N2
RDPRLPKTLLVYVAP	SPIDR	686	Q14159
VRYVPVRPRPPITLL	SAP130	886	Q9H0E3
FPTPYLRVPVTLPER	HIVEP3	1391	Q5T1R4
RFYLPGTSRPPIIVS	SMC6	551	Q96SB8
EEYRPPPLDSIRLPR	SMIM44	21	A0A286YF18
TPVLLSVLYPPDRPK	SIGLEC1	786	Q9BZZ2
LVIPPVLERTYPALE	PSME4	431	Q14997
IPYGERITLRPDPLP	YLPM1	1656	P49750
NPPIVRFPLPLERIS	nan	56	Q5VV11
KAPRLLPAPRAYLVP	ZNF598	736	Q86UK7
RQGLYDRLPPLPVTP	VAT1	96	Q99536
DDLPLTAVPPYRLRV	TTC7B	126	Q86TV6
YPEPRVLTLVRITPV	VPS13B	2341	Q7Z7G8
RYVVEPPRLPLAVSL	ZDHHC8	251	Q9ULC8
PELLVAPLQRLTRYP	PLEKHG7	431	Q6ZR37
GVRVPLLGSRLPYQP	SNAPC4	1291	Q5SXM2
PGPSVPRLRLSYRDL	SEMA3G	26	Q9NS98
PLPGLRGSPVERLYL	TPTE2P1	31	Q5T6R2
PLLLQYIPRPTSRVG	TRIM49B	396	A6NDI0
YLLRLPQAETPLPLP	ZNF831	941	Q5JPB2
YLLNIPGPIDIPSRL	ZFC3H1	1716	O60293
SPPPKRPRIAYLSEV	ZNF76	396	P36508
LGVPPRSLALPPIRY	WFIKKN2	26	Q8TEU8
PVVLGPRVRALQLPY	KLK10	146	O43240